StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Down 50.0 %
Shares of NYSE NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.13.
Navidea Biopharmaceuticals Company Profile
See Also
- Five stocks we like better than Navidea Biopharmaceuticals
- What Does Downgrade Mean in Investing?
- Can TikTok Stock Picks Really Make You Rich?
- Following Congress Stock Trades
- The “Quality” Rotation: Back to Basics Investing
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.